BioTelemetry, Inc. Reports Fourth Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
BioTelemetry (BEAT) Tops Q4 EPS by 1c
February 26, 2020 4:27 PM ESTBioTelemetry (NASDAQ: BEAT) reported Q4 EPS of $0.48, $0.01 better than the analyst estimate of $0.47. Revenue for the quarter came in at $112 million versus the consensus estimate of $110.18 million.
Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented:Our fourth quarter capped off a strong year for BioTelemetry, highlighted by our highest quarterly revenue and adjusted EBITDA in company history. These results came in... More
